NEW HOPE, PA — Orchestra BioMed Holdings Inc. (Nasdaq: OBIO) has granted stock options covering 85,500 shares to five newly hired employees, using an inducement plan designed to support recruitment as the medical technology company advances two late-stage cardiovascular device programs.
The awards were approved June 1 by the compensation committee of the company’s board of directors and were issued under the Orchestra BioMed Holdings Inc. 2025 New Hire Inducement Plan.
According to the company, the grants were made as employment inducements in accordance with Nasdaq Listing Rule 5635(c)(4), which allows companies to issue equity awards to new employees outside of shareholder-approved compensation plans.
The stock options will vest over a four-year period.
While the equity grants are modest in size, they offer a glimpse into hiring activity at Orchestra BioMed as the company continues clinical development efforts across its core product portfolio.
Orchestra BioMed is developing Atrioventricular Interval Modulation (AVIM) Therapy, an investigational treatment designed to reduce blood pressure in patients with hypertensive heart disease who require pacemakers. The program is being developed through a strategic collaboration with Medtronic.
The company is also advancing Virtue Sirolimus AngioInfusion Balloon, a drug-delivery angioplasty balloon system intended to treat atherosclerotic artery disease.
Both programs are currently undergoing pivotal clinical trials and have received Breakthrough Device Designation from the U.S. Food and Drug Administration for multiple indications.
For development-stage medical technology companies, equity compensation is commonly used to attract and retain specialized talent while preserving cash resources for clinical, regulatory and commercialization activities.
Orchestra BioMed disclosed the grants as required under Nasdaq rules governing inducement awards to newly hired employees.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.